Research graph
References from Pharmacokinetic and safety analysis of biosimilar adalimumab in healthy volunteers in Bangladesh. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1111/bcp.14330
10.1111/bcp.14330 · 2020 · External reference
10.1590/1414-431x20187927
10.1590/1414-431x20187927 · 2019 · External reference
10.1016/j.jep.2020.113039
10.1016/j.jep.2020.113039 · 2020 · External reference
10.2174/0929867324666170817152554
10.2174/0929867324666170817152554 · 2019 · External reference
10.3390/biomedicines4030014
10.3390/biomedicines4030014 · 2016 · External reference
10.1136/bmjopen-2016-011941
10.1136/bmjopen-2016-011941 · 2016 · External reference
Unresolved reference
2002 · External reference
Unresolved reference
External reference
10.1136/annrheumdis-2012-eular.3077
10.1136/annrheumdis-2012-eular.3077 · 2013 · External reference
10.1111/bcp.12656
10.1111/bcp.12656 · 2015 · External reference
10.1080/13543784.2016.1255724
10.1080/13543784.2016.1255724 · 2016 · External reference
10.1007/s40744-020-00259-8
10.1007/s40744-020-00259-8 · 2021 · External reference
10.1016/j.yrtph.2020.104587
10.1016/j.yrtph.2020.104587 · 2020 · External reference
10.1186/s40360-021-00545-3
10.1186/s40360-021-00545-3 · 2022 · External reference
10.1111/bcp.13245
10.1111/bcp.13245 · 2017 · External reference
10.1111/jcpt.12583
10.1111/jcpt.12583 · 2017 · External reference
10.1111/bcp.13039
10.1111/bcp.13039 · 2016 · External reference
10.1097/mjt.0000000000000391
10.1097/mjt.0000000000000391 · 2016 · External reference
